IGF1 and metabolic dysfunction-associated steatotic liver disease: In addition, anabolic hormones such as insulin-like growth Factor1 (IGF-1) also contribute to the progression of sarcopenia and lean NAFLD (78), as well as non-lean NAFLD (68).